7th Annual Conference- Eighth annual conference
- 2016 Depression Center Conference
- Eleventh Annual Depression Center Conference
- Thirteenth Annual Depression Conference
- JBeck cb
- Boadie Dunlop CV
- 2022 Annual Conference Schedule
- 16th Annual Conference
14th Annual Conference of the UofL Depression Center
Depression Center Annual Conference Goes Virtual
Because of the Covid-19 pandemic, the 14th Annual Conference of the UofL Depression Center will be held remotely on Novemeber 5th and 6th, 2020. As in past years, the program will feature leading experts in mental health treatment and will offer rich opportunities for learning. This year’s conference will feature keynote speakers, Judith Beck, Ph.D., one of the world’s most influential psychotherapists, and Boadie Dunlop, M.D., a top authority on the novel uses of psychedelics in treatment of depression. Full CME credits will be available to registrants.
Moving Ahead: Treating Depression in 2020 and Beyond
November 5th and 6th
A Virtual Conference
November 5th
8:20-8:30 AM
Welcome: Jesse H. Wright, M.D., Ph.D.
8:30-9:30 AM
Building Hope: Judith Beck, Ph.D.
Abstract: Hopelessness is a key feature of depression, and acute hopelessness is a key factor in suicidality. In this presentation, I will focus on conceptualizing hopelessness according to a cognitive behavioral framework, eliciting clients’ hopeless cognitions, helping clients respond to their hopeless thinking, and using a variety of techniques to increase hopefulness.
Objectives:
To identify hopeless cognitions
To evaluate and respond to hopeless cognitions
To use cognitive and behavioral techniques to increase hope
9:30-10:30 AM
Mindful Movement in Clinical Practice: Paul Salmon, Ph.D.
Or
Covid-19 and Mental Health: David E. Casey, M.D.
November 6th
8:20-8:30 AM
Welcome: Jesse H. Wright, M.D., Ph.D.
8:30-9:30 AM
Psychedelics in the Treatment of Depression: Boadie Dunlop, M.D.
Objective: Attendees will be able to state the theorized therapeutic mechanisms of psychedelic drugs being studied for psychiatric disorders and understand the evidence base currently supporting their efficacy and safety.
9:30-10:30 AM
Helping Patients Work Through Grief and Loss: Kathie Vincent, M.D. and Jodene Miller, LCSW.
Or
The Genie is Out of the Bottle: Technology and Social Media in Clinical Practice: Robert Caudill, M.D. and Christopher Peters, M.D.
Speaker Bios:
Judith S. Beck, PhD
Judith S. Beck, PhD, is President of the Beck Institute for Cognitive Behavior Therapy (www.beckinstitute.org), a nonprofit organization that provides state-of-the-art training and certification in CBT to individuals and organizations; offers online courses on a variety of CBT topics; and serves as a leading global resource in CBT. She is also Clinical Professor of Psychology in Psychiatry at the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania. She has written over 100 articles and chapters as well as several books for professionals and consumers; has made hundreds of presentations, nationally and internationally, on topics related to cognitive behavior therapy; is the codeveloper of the Beck Youth Inventories and the Personality Belief Questionnaire; and has won numerous awards for her contributions to the field of CBT. She continues to treat clients through Beck Institute’s in-house clinic.
Boadie W. Dunlop, MD
Dr. Boadie Dunlop is Associate Professor and Director of the Mood and Anxiety Disorders Program (MAP) at Emory University. He graduated from Mayo Medical School in 1997, completed his Residency in Psychiatry at Emory in 2001 and became Director of MAP in 2006. His clinical research program is focused on the neurobiology, psychopharmacology, and personalized treatment of major depression, bipolar disorder, and post-traumatic stress disorder. He has served as an investigator for more than 70 clinical studies of medication and psychotherapy treatments for these conditions, and is currently studying psilocybin’s efficacy in major depression and the mechanisms underlying the potential therapeutic benefits of MDMA for PTSD. Dunlop has authored fourteen book chapters and over 100 research papers in psychiatry and is a leader in the area of medication-assisted psychotherapy. In addition, He also serves as the course director for the Mood and Anxiety Disorders lecture series at Emory and provides supervision in psychopharmacology for Emory Psychiatry residents.